Where Interpretation Breaks

A CGM claim about a person without diagnosed diabetes can sound convincing and still answer the wrong question. This chapter focuses on the points where a glucose trace stops carrying the meaning someone wants to assign to it: the recording may be too short, the daily context may be unclear, the population may not match, or the evidence may support association rather than diagnosis. The practical capability is to audit the match between data and conclusion before trusting a sophisticated-looking metric.

The problem is not that CGM is unreliable in every use. Different uses demand different standards. A trace may be adequate for describing what happened during a recorded period but inadequate for identifying a disease. It may support a research association but not a personal cutoff. It may help a structured lifestyle program test a behavior while remaining unable to prove that the behavior will change weight. Interpretation breaks when those boundaries are ignored.

Start with the question, not the number

The first decision is what the trace is supposed to do. Four questions appear repeatedly in the evidence.

Description asks: What did glucose do during this recording? The answer can concern average level, variation, or temporal pattern. It stays close to the observations and should include the recording window and surrounding context.

Research stratification asks: Do people with different CGM features also differ in a measured outcome? The answer may involve associations with insulin-related measures, carotid intima-media thickness, or liver ultrasound characteristics. It can identify a group worth studying without assigning a diagnosis to each member.

Structured feedback asks: Can seeing a response help a person and a program choose or sustain a behavior? The systematic review reports evidence of improved mean blood glucose, adherence, and specific dietary modifications in some non-diabetic settings. That is an intervention question, and its answer depends on the program and the outcome.

Clinical diagnosis asks: Does this person meet validated criteria for a condition or need a clinical decision? The evidence considered here does not establish CGM-based diabetes diagnostic criteria. A rich trace cannot create diagnostic authority merely by being continuous.

The same reading can appear in all four conversations, but its role changes. A high post-meal value may be a descriptive observation. Repeated patterns might be relevant to a research analysis. A program might use a response as feedback. None of those steps, by itself, establishes a diagnosis.

flowchart TD A["Identify the intended claim"] --> B["Describe the observed pattern"] A --> C["Research association or stratification"] A --> D["Structured lifestyle feedback"] A --> E["Clinical diagnostic question"] B --> F["Check recording duration, continuity, and context"] C --> G["Check population, comparator, outcome, and study design"] D --> H["Check program, behavior, and measured outcome"] E --> I["Additional clinical tests and evaluation required"] F --> J{"Does the evidence fit the claim?"} G --> J H --> J J -->|"Yes, for this bounded use"| K["State the limited conclusion"] J -->|"No"| I C --> L["Research cluster is not a personal cutoff"]

This map is deliberately not a personal scoring tool. Its purpose is to make the stopping points visible. When the evidence does not fit the intended use, the responsible response is to narrow the claim or seek a different kind of evidence, not to squeeze more certainty out of the same trace.